BATS BZX Real-Time Price
As of 11:48am ET
| -0.07 / -1.07%|
The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 15.00. The median estimate represents a +323.73% increase from the last price of 6.49.
The current consensus among 5 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.